Company
Headquarters: Scottsdale, AZ, United States
Employees: 128
$1.9 Million
USD as of July 1, 2022
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $63.92 B |
| Cencora, Inc. | $43.41 B |
| Cardinal Health, Inc. | $26.02 B |
| Henry Schein, Inc. | $9.72 B |
| Sinopharm Group Co. Ltd | $8.04 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Swiftsure International, Inc. is a holding company operating through its subsidiary that operates as a contract research company. It offers various services for the design, placement, performance, and management of clinical trial programs. The company's service capabilities include design of protocols, operations manuals, identification and recruitment of trial investigators, initiation of sites, monitoring, site visits and collection of data, interpretation of trial results, and report preparation. It offers services to support research and development of biotechnology, pharmaceutical, and medical device companies in the United States and Canada. The company was formerly known as Holmes Biopharma, Inc. and changed the name to Swiftsure International, Inc. in September, 2010. The company was founded in 1998 and is based in Scottsdale, Arizona.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Swiftsure International, Inc. has the following listings and related stock indices.
Stock: OTC: HLMB wb_incandescent